Men with a particular genetic subtype of the steroid biosynthesis enzyme HSD3B1 may exhibit resistance to combined radiation and hormone therapy for prostate cancer, according to new Cleveland Clinic-led research published in Journal of Clinical Investigation.
from Medical Xpress - latest medical and health news stories https://ift.tt/U2CoczI
